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Sleep is involved in the regulation of major organ functions in the human body, and disrup-
tion of sleep potentially can elicit organ dysfunction. Obstructive sleep apnea (OSA) is the
most prevalent sleep disorder of breathing in adults and children, and its manifestations
reﬂect the interactions between intermittent hypoxia, intermittent hypercapnia, increased
intra-thoracic pressure swings, and sleep fragmentation, as elicited by the episodic changes
in upper airway resistance during sleep. The sympathetic nervous system is an important
modulator of the cardiovascular, immune, endocrine and metabolic systems, and alter-
ations in autonomic activity may lead to metabolic imbalance and organ dysfunction. Here
we review how OSA and its constitutive components can lead to perturbation of the auto-
nomic nervous system in general, and to altered regulation of catecholamines, both of
which then playing an important role in some of the mechanisms underlying OSA-induced
morbidities.
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INTRODUCTION
Obstructive sleep apnea (OSA) is the most prevalent form of sleep
disordered breathing. It has been estimated that 2–4% of the adult
population in western countries suffer from clinically signiﬁcant
OSA (Young et al., 2002), and in children the prevalence is esti-
mated to be between 1 and 3%, although considerable variation
exists, most likely reﬂecting the absence of large-scale epidemio-
logical studies with accurate phenotype assessments (Newacheck
and Taylor, 1992; Guilleminault et al., 2005; Lumeng and Chervin,
2008). In recent years, OSA is becoming increasingly more preva-
lent as the average bodyweight of the pediatric population is rising
(Tauman and Gozal, 2006).
Obstructive sleep apnea is characterized by repetitive collapse
or near collapse of the upper airway during sleep, and these repet-
itive events impose substantial adverse effects on multiple organ
systems in both adults and children, thereby emphasizing the
importance of improving our understanding on the underlying
pathophysiology of this disorder. As a result of these mechani-
cal changes in the airway, hypoxemia, and hypercapnia develop,
which further stimulate respiratory effort (Owens et al., 2008).
However, without airway opening the increased drive is ineffec-
tive at increasing ventilation, such that generally, albeit not always,
the apnea/hypopnea typically continues until the patient arouses
from sleep and terminates the obstruction. After airway reopen-
ing, hyperventilation occurs to reverse the blood gas disturbances
that developed during the respiratory event (Eckert et al., 2009).
The repetitive nature of these apneas and the arousal events results
in signiﬁcant sleep fragmentation and promote excessive daytime
sleepiness (Stepanski, 2002), fatigue, neurocognitive dysfunction,
and increased cardiovascular morbidity (Kim et al., 2011).
Increased intra-thoracic pressure swings are an important com-
ponent of OSA, and increased negative inspiratory intra-thoracic
pressures generated against the occluded pharynx increase the left
ventricular (LV) transmural pressures, and hence augment the
LV afterload. These changes also increase venous return, aug-
menting right ventricular (RV) pre-load, whereas OSA-induced
hypoxia will result in pulmonary vasoconstriction, therefore lead-
ing to increases in RV afterload. Taken together, RV distension,
impairment of LV ﬁlling, and increased sympathetic activity will
occur, and can synergistically increase myocardial oxygen demand
in a contextual setting in which apnea-related hypoxia will reduce
tissue oxygen delivery (Kasai and Bradley, 2011). Upon arousal
from sleep, sympathetic activity, blood pressure, cardiac output,
and heart rate rapidly increase, resulting in more increased car-
diac oxygen demand at a time when arterial oxygen saturation is
at its lowest level (Eckert et al., 2009). This can precipitate more
severe myocardial ischemia and impair cardiac contractility and
diastolic relaxation. Over time, such stresses may contribute to
development or progression of cardiac remodeling, hypertrophy,
and failure, while also prescribe an array of changes that may
adversely impact the vasculature.
Based on aforementioned alterations as induced by OSA, it
becomes apparent that the autonomic nervous system (ANS)
activity is likely to play important pathophysiological roles. There-
fore, themajor aim of the current paper is to review the alterations
in ANS activity and catecholaminergic systems in the context of
sleep apnea. The ANS of mammals is involved with involuntary
movements, actions, and organ functioning. This system can be
further subdivided into the sympathetic motor system which is
involved with quick responses, and the parasympathetic motor
system which is involved with slower relaxing responses. Sympa-
thetic stimulationmay result in excitatory, dilatory, and inhibitory
effects on vessels, muscles, and organs. Consequently, a large body
of research has been conducted to understand the autonomic
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alterations that occur with the transition from waking to sleep,
and throughout sleep state dynamics. During normal sleep there
are changes in sympathetic nerve activity (SNA) that are tightly
regulated by sleep state distribution. Indeed, SNA, blood pressure,
and heart rate are lower in normal subjects while they are in deep
non-REM (NREM) sleep than when awake, and during rapid eye
movement (REM) sleep SNA increases above the levels recorded
during wakefulness, even though blood pressure and heart rate
return to the same levels recorded during wakefulness (Hornyak
et al., 1991; Somers et al., 1993a).
In OSA patients, the repetitive respiratory events lead to inter-
mittent hypoxia (IH) and CO2 retention, both of which can
augment SNA via stimulation of central and peripheral chemore-
ceptors (Somers et al., 1989a). Carotid sinus baroreceptorswill also
augment SNA coincident with the time in which they are being
unloaded, because of the reduction in blood pressure and stroke
volume during obstructive apneic events. Apnea also enhances
SNA by eliminating reﬂex inhibition of SNA arising from pul-
monary stretch receptors (Somers et al., 1989b). Sleep fragmenta-
tion and arousals from sleep at apnea termination also augment
SNA and reduce cardiac vagal activity, although spontaneous
arousals per se are associated with acute increases in SNA along
with decreases in parasympathetic activity, which can precipitate
post-apneic surges in blood pressure and heart rate (Horner et al.,
1995, p. 67; Figure 1). These adverse autonomic effects induced
by OSA may persist even during waking hours (Spaak et al., 2005;
Kasai and Bradley, 2011).
CATECHOLAMINE PRODUCTION AND SYMPATHETIC
ACTIVATION
Catecholamines (CAs; e.g., norepinephrine and epinephrine)
are key hormones that prepare the body for one of its most
primeval reactions: the“ﬁght or ﬂight”response. CAs increases the
contractility and conduction velocity of cardiomyocytes, leading
to increased cardiac output and a rise in blood pressure. More-
over, they facilitate breathing by bronchodilation, and urge the
production of vital energy by mobilizing the body’s metabolic
reserves (lipolysis and glycogenolysis). Past concepts held that the
adrenal medulla and the postganglionic ﬁbers in the sympathetic
nervous system were the only systems responsible for the produc-
tion, storage, and release of CAs. More recent ﬁndings suggest that
phagocytic cells, lymphocytes (Flierl et al., 2008), and adipocytes
(Vargovic et al., 2011) can also synthesize and release CAs. Because
the brain and the immune system are some of the major adap-
tive systems, and communicate with each other extensively in an
attempt to regulate body homeostasis, a common “language” is
needed to facilitate this crosstalk. Key systems involved in this
crosstalk are the hypothalamic–pituitary–adrenal (HPA) axis and
the ANS, consisting of the adrenergic sympathetic nervous sys-
tem, the vagus-mediated parasympathetic nervous system, and
the enteric nervous system (Elenkov et al., 2000).
The synthesis of CAs relies on tyrosine and the activity of
two key enzymes, namely tyrosine hydroxylase (TH), which is
known to be the rate-limiting step in catecholamine synthesis,
and dopamine β-hydroxylase (DBH), which converts dopamine
to norepinephrine (Elenkov et al., 2000). The catecholamine neu-
rotransmitters are dopamine, norepinephrine, and epinephrine.
Although both norepinephrine and the methylated derivative epi-
nephrine are stored in synaptic vesicles of neurons, epinephrine is
not a neuromediator at the postganglionic sympathetic endings,
with norepinephrine constituting the principal neurotransmitter
of sympathetic postganglionic endings.
Tyrosine is transported into catecholamine-secreting neurons
and adrenal medullary cells where catecholamine synthesis takes
place. The ﬁrst step in the process requires TH with tetrahydro-
biopterin (H4B) as cofactor. The hydroxylation reaction generates
FIGURE 1 | Schematic diagram underlying the sympathetic nerve system activation associated with obstructive sleep apnea syndrome that may lead
to increased cardiovascular disease risk.
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DOPA (3,4-dihydrophenylalanine). DOPAdecarboxylase converts
DOPA to dopamine, dopamine β-hydroxylase converts dopamine
to norepinephrine and phenylethanolamine N -methyltransferase
converts norepinephrine to epinephrine. Within the substantia
nigra and some other regions of the brain, synthesis proceeds only
to dopamine. Within the adrenal medulla, dopamine is converted
to norepinephrine and epinephrine (Hui et al., 2003). Once syn-
thesized, dopamine, norepinephrine, and epinephrine are pack-
aged in granulated vesicles. Within these vesicles, norepinephrine
and epinephrine are bound to ATP and chromogranin A.
The actions of norepinephrine and epinephrine are exerted via
receptor-mediated signal transduction events. There are three dis-
tinct types of adrenergic receptors: α1,α2, and β, with each includ-
ing several sub-classes that exhibit different activity depending on
the receptor in the target organ. Dopamine binds to dopamin-
ergic receptors identiﬁed as D-type receptors and there are four
sub-classes identiﬁed as D1, D2, D4, and D5. Activation of the
dopaminergic receptors results in activation of adenylate cyclase
(D1 and D5) or inhibition of adenylate cyclase (D2 and D4). In
response to stress stimuli such as fear, pain, extreme temperatures,
hypoxia, or hypotension, CAs are released directly into the circu-
lation, activating peripheral adrenergic receptors with subsequent
chronotropic and inotropic effects on the heart, redistribution of
blood ﬂow to organs and muscles, and release of energy through
glycolysis and lipolysis. This systemic effect also includes sensitiz-
ing certain receptors to subsequent sympathetic or somatic nerve
stimulation, along with concomitant inhibition of pain sensation,
thus facilitating the coordinated responses that characterize the
“ﬁght or ﬂight” situation (Smith et al., 1998).
ASSESSMENT OF AUTONOMIC FUNCTION AND NORMAL
SLEEP PHYSIOLOGY
Direct measurements of autonomic activity, particularly during
sleep, are not an easy task, and require invasive approaches. Con-
sequently, the vast majority of such studies have been conducted
using animalmodels.However, recent technological advances have
enabled direct measurements of sympathetic activity to be per-
formed for extended periods of time in human muscle. Further-
more, surrogate markers of ANS activity such as linear and non-
linear dynamic analyses of heart rate variability (HRV), peripheral
arterial tonometry (PAT), continuous beat-to-beat blood pressure
monitoring, non-invasive radionuclide imaging, or quantitation
of serum and urine catecholamines and their metabolic products
have emerged as useful markers of changes in ANS, thereby per-
mitting more extensive probing of the autonomic system in health
and disease (Smith et al., 1998).
Sleep is involved in the regulation of peripheral organ func-
tion, such as endocrine and cardiovascular function, and speciﬁc
changes in peripheral organ systems occur during both REM and
non-REM (NREM) components of sleep in healthy individu-
als. One well established sleep-associated cardiovascular change
is the decrease in blood pressure and heart rate that occurs dur-
ing sleep in a variety of species, a phenomenon generally referred
to as “blood pressure dipping” (Antic et al., 2001). The sleep-
related decrease in blood pressure occurs in addition to the blood
pressure changes induced by the circadian clock and changes in
body posture that typically accompany sleeping behaviors. Blood
pressure dipping is contingent upon a reduction in global sym-
pathetic tone activity (reﬂecting increased parasympathetic tone
along with sympathetic withdrawal) as non-dippers exhibit an
increase in sympathetic tone at sleep onset (Ziegler, 2003). Sleep
state transitions are also accompanied by other changes in the car-
diovascular system, for example, when transitioning from NREM
sleep toREMsleep,bloodpressure,andheart rate typically increase
and become more unstable (Schwimmer et al., 2010). These phe-
nomena are altered in OSA patients, and are believed to underlie
the increased risk for development of hypertension, one of the
important cardiovascular morbidities of the disorder.
RODENT MODELS OF OSA AND AUTONOMIC FUNCTION
The manifestations of OSA reﬂect the interactions of IH, inter-
mittent hypercapnia, increased intra-thoracic pressure swings, and
sleep fragmentation, as elicited by the episodic changes in upper
airway resistance during sleep. Data from clinical studies and ani-
mal models, particularly those reﬂecting exposures to IH, have
revealed the induction of sympathetic nerve stimulation leading
to vasoconstriction and hypertension, whereby both baro- and
chemoreceptors activity and regulation are involved in the sympa-
thetic control of blood pressure (Guyenet, 2006). The baroreﬂex
provides a negative feedback loop inwhich elevated blood pressure
inhibits sympathetic outﬂow, decreases heart rate, and, thus, low-
ers blood pressure. In a similar fashion, decreased blood pressure
activates baroreﬂex mechanisms, causing heart rate increases, and
blood pressure to rise (Golbidi et al., 2011). Attenuated barore-
ceptor sensitivity is proposed to lead to increased sympathetic
activation. In a recent review, Prabhakar and Kumar (2010) con-
cluded that patients with OSA do exhibit a reduction in baroreﬂex
sensitivity, as evidenced by attenuated heart rate and vascular resis-
tance responses to baroreceptor activation, and that restoration of
baroreﬂex sensitivity will occur after treatment with CPAP (Carl-
son et al., 1993; Bonsignore et al., 2006; Monahan et al., 2006;
Cooper et al., 2007). Similarly, when rodents were exposed to IH,
attenuated baroreﬂex function, sensitivity and activity, or changes
in the reﬂex set point depending on the severity of the hypoxia
stimulus developed over time (Brooks et al., 1999; Greenberg et al.,
1999; Lai et al., 2006; Gu et al., 2007; Peng et al., 2012). These
changes also led to exaggerated sympathetic activity and eventu-
ally elicited elevations of blood pressure and the elimination of the
normal blood pressure dipping during sleep.
On the other hand, the arterial chemoreceptors, especially the
carotid bodies which operate as the primary sensors for hypoxia
and the ensuing carotid chemoreﬂex will activate SNA, elevate
blood pressure, and stimulate breathing (Prabhakar and Kumar,
2010). Since the introduction of a rodent IH model by Fletcher
et al. (1992), augmented chemoreﬂex-stimulated sympathetic out-
ﬂow was clearly identiﬁed (Bao et al., 1997), and found to be
mediated via the renin–angiotensin system and also via themodu-
lation of oxygen-sensing in carotid bodies by activation of Hypoxia
Inducible Factor-1 (HIF-1) and down regulation of HIF-2, as well
as via changes in oxidative stress activity (La Rovere et al., 1998;
Fletcher et al., 2002; Peng et al., 2003; Prabhakar et al., 2009). Fur-
thermore, stimulation of carotid bodies by IH is also associated
with a reduction in baroreﬂex sensitivity in cats (Rey et al., 2004),
rats (Soukhova-O’Hare et al., 2006a;Gu et al., 2007; Lin et al., 2008;
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Yan et al., 2008, 2009), and mice (Lin et al., 2007). These effects of
chronic IH on carotid body function and sensitivity are reversed
completely after re-exposure to normoxia in adult subjects (Peng
et al., 2003), but not if IH exposures occur during a critical period
of postnatal development (Soukhova-O’Hare et al., 2006b, 2008).
The reversible nature of the carotid body responses to chronic
IH in adults could explain why CPAP therapy reverses some of
the adverse cardio-sympathetic effects inOSA patients (Prabhakar
and Kumar, 2010). Exposure of mice to more than 30 days of IH
elicited elevated systemic bloodpressure that persisted even during
normoxia, along with enhanced sympathoadrenal activity as mea-
sured by catecholamine levels, especially norepinephrine. Surgical
denervation of peripheral chemoreceptors or adrenal demedu-
lation and chemical denervation of the peripheral sympathetic
nervous system prevented the increase in arterial blood pressure
(Lesske et al., 1997; Dematteis et al., 2008; Gonzalez-Martin et al.,
2009). A more recent study by Gonzalez-Martin et al., 2011),
who exposed rats to 15 days of IH, concluded that IH leads to
a bias in the integration of the inputs arising from the carotid
body characterized by a diminished drive of ventilation along
with an exaggerated activation of brainstem sympathetic neu-
rons. In conclusion, chronic IH selectively augments the carotid
body sensitivity to hypoxia resulting in a long lasting activation
of chemosensory inputs to the medial and commissural nuclei
of the solitary tract (Prabhakar et al., 2001; Kara et al., 2003).
In parallel, extensive changes occur in central neural regions
governing autonomic system nervous system outﬂow and other
integrated outputs such as respiration (Ai et al., 2009). These
changes notwithstanding, a multiplicity of interactions and addi-
tionalmechanisms are likely involved and are dependent on the age
at which IH occurs, the severity, cycle duration, and overall dura-
tion of IH, and the association of additional perturbations such as
hypercapnia or hypocapnia (Waters and Gozal, 2003; Reeves et al.,
2006; Mahamed and Mitchell, 2008; Iturriaga et al., 2009; Zoccal
et al., 2009; Kline, 2010; Xing and Pilowsky, 2010; Baker-Herman
and Strey, 2011; Dodig et al., 2011; Molkov et al., 2011; Prabha
et al., 2011).
A characteristic feature of mammalian sleep is decreased pos-
tural muscle tone, especially during REM sleep. The suppression
of motor activity also involves respiratory muscles, particularly
in those that combine postural and respiratory functions, such as
the intercostal and pharyngeal muscles; this effect of REM sleep is
modulated by catecholamine secretion. The genioglossus muscle,
an important upper airway dilator is innervated by the hypoglossal
motoneuron, and both norepinephrine and serotonin lead to exci-
tation of orofacial motoneurons, including those that innervate
upper airway muscles, and both noradrenergic (NE) and sero-
tonergic brainstem neurons have been shown in animal models
to reduce their activity during slow-wave sleep and stop ﬁring
during REM sleep (Aston-Jones and Bloom, 1981; Kubin et al.,
1998; Fenik et al., 2005; Rukhadze and Kubin, 2007). These data
suggest that sleep-related withdrawal of aminergic excitation may
cause decrements of motoneuronal activity, thereby contributing
to sleep-related upper airway hypotonia. Chan and colleagues have
conﬁrmed this hypothesis in rats, and identiﬁed an endogenous
noradrenergic drive that contributes to the genioglossus muscle
activity. Furthermore, withdrawal of the excitation is mediated
by alpha1-adrenergic receptors, which play a major role of sleep-
related suppression of activity in hypoglossal motoneurons (Chan
et al., 2006).
Recurrent arousals in the context of OSA lead to sleep frag-
mentation and are associated with state-related increases in the
sympathetic activity to peripheral arteries, that in turn may lead
to large repetitive blood pressure rises that can be as high as 60–
80mmHg. These oscillations in blood pressure are thought to be
important risk factors in the development of vascular events (Bao
et al., 1999; Kohler and Stradling, 2010). Horner et al. (1995) stud-
ied tracheostomized dogs and showed that arousals from sleep are
associated with marked increases in heart rate that can be atten-
uated by sympathetic blockade. Evidence for alterations in the
sympathetic activity that accompanies sleep fragmentation include
increased levels of cortisol, epinephrine, andnorepinephrine along
with increased heart rate and systolic blood pressure (Andersen
et al., 2004, 2005; Everson and Crowley, 2004; Perry et al., 2007;
Tartar et al., 2009).
AUTONOMIC ALTERATIONS IN ADULT PATIENTS WITH OSA
In combination with other co-factors, sympathetic and cate-
cholaminergic alterations are believed to play an important role
in the pathophysiology of the cardiovascular morbidity in adults
with OSA (see Table 1 for summary). The cumulative evidence
that has emerged in the last three decades using multiple meth-
ods to quantify sympathetic activity in patients with OSA sup-
ports this putative association. Indeed, OSA patients demonstrate
a reduction in vagal modulation of HRV in comparison with
controls (Aydin et al., 2004; Kesek et al., 2009; Bianchi et al.,
2010; Balachandran et al., 2012), and such alterations in car-
diac sympathetic and parasympathetic modulation are improved
after treatment with either CPAP or upper airway surgery (Cheng
et al., 2011; Choi et al., 2011; Gapelyuk et al., 2011). However,
we should acknowledge that although HRV measurements pro-
vide non-invasive probes into ANS function, they are fraught with
substantial limitations (Poupard et al., 2011), such that alternative
methods have been used. However, discussion of the pros and cons
of such methodologies is clearly beyond the scope of this review.
Hypertension is one of the leading cardiovascular morbidities
of OSA, and enhanced sympathetic activity is believed to play a
fundamental role in the blood pressure elevation. Thus, beat-to-
beat monitoring of blood pressure changes has been used to assess
changes in sympathetic activity in OSA patients. In general, OSA
patients all levels of severity demonstrate increases in both systolic
and diastolic blood pressure during sleep andwakefulness (Table1;
Kohler et al., 2008). Furthermore, high blood pressure in the con-
text of OSA was resistant to conventional anti-hypertensive drug
therapy (Pedrosa et al., 2011), with in some instances resembling
pheochromocytoma, with catecholamine surges and malignant
hypertension becoming manifest (Cheezum and Lettieri, 2010).
Although a large group of studies have demonstrated that blood
pressure elevations were attenuated by treatment of OSA (Weiss
et al., 2007; Friedman and Logan, 2009; Table 1), the changes in
blood pressure have traditionally been modest (Duran-Cantolla
et al., 2010), even if the strength of the association may apply
only to selected subsets of the general population (Cano-Pumarega
et al., 2011). Indeed, there are reported differences regarding the
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Table 1 | Summary of autonomic nervous system alterations in adult OSA patients.
Modality Reference Effect
Blood pressure Bixler et al. (2000), Suzuki et al. (1996), Borgel et al. (2004), Heitmann
et al. (2004), Dhillon et al. (2005), Pepperell et al. (2002), Faccenda et al.
(2001), Dernaika et al. (2009), Robinson et al. (2008), Patruno et al.
(2007), Wilcox et al. (1993), Hui et al. (2006), Duran-Cantolla et al. (2010),
Marrone et al. (2011)
OSA is associated with elevated blood pressure that
is attenuated by CPAP therapy; differences emerge
regarding the level of reduction in BP after treat-
ment, the circadian time at which reduction occurs
(sleep/wakefulness), and whether the systolic or
diastolic component is more affected
Urine and blood
catecholamine levels
Fletcher et al. (1987), Baruzzi et al. (1991), Ziegler et al. (1997),
Minemura et al. (1998), Loredo et al. (1999), Elmasry et al. (2002),
Sukegawa et al. (2005), Drager et al. (2007), Kohler et al. (2008),
Comondore et al. (2009), Zhang et al. (2011), Bao et al. (2002), Ziegler
et al. (2001), Kohler et al. (2011)
OSA patients demonstrate sustained elevation in
catecholamine levels that are attenuated by treat-
ment, and are elevated again by treatment with-
drawal. Hypertensive patients will experience a
larger reduction in catecholamine levels
Muscle synaptic nerve
activity (MSNA)
Imadojemu et al. (2007), Usui et al. (2005), Narkiewicz et al. (1999a),
Gilmartin et al. (2008, 2010), Xie et al. (1999), Morgan et al. (1996)
Higher basal MSNA in OSA patients, which is atten-
uated with treatment
Heart rate variability
(HRV)
Balachandran et al. (2012), Bianchi et al. (2010), Aydin et al. (2004), Kesek
et al. (2009), Choi et al. (2011), Cheng et al. (2011), Gapelyuk et al. (2011)
Reduced HRV is found in OSA patients, and is
improved after treatment with CPAP or upper airway
surgery
reduction in systolic and diastolic components of blood pressure,
with only daytime diastolic blood pressure being affected by treat-
ment in some studies, and with both systolic and diastolic values
being favorably reduced during sleep in other studies (Voogel et al.,
1999; Norman et al., 2006; Marrone et al., 2011), or during day-
time (Wilcox et al., 1993; Ip et al., 2004). Furthermore, only systolic
blood pressure was reduced during the night after treatment in yet
other studies (Suzuki et al., 1993). These differences in the response
to therapy can be attributed to a large number of confounders such
as ethnicity, gender, age, presence of underlying diseases, as well
as genetic polymorphisms. It is possible that the more favorable
reduction in diastolic blood pressure reﬂects its dependency on
arteriolar tone, which is highly inﬂuenced by sympathetic activity,
the latter being high in patients withOSA both duringwakefulness
and during sleep (Marrone et al., 2011).
Because of the unique roles that catecholamines play in
the transduction of sympathetic activity, multiple studies have
assessed their concentrations, and shown the presence of ele-
vated levels of catecholamines in both urine and plasma among
patients with OSA. Some of these studies also showed that cate-
cholamine levels were attenuated after treatment, thereby lead-
ing to the proposition that catecholamines levels may serve
as a surrogate biomarker for OSA (Fletcher et al., 1987; Baruzzi
et al., 1991; Ziegler et al., 1997; Minemura et al., 1998; Loredo
et al., 1999; Elmasry et al., 2002; Sukegawa et al., 2005;Drager et al.,
2007; Kohler et al., 2008; Comondore et al., 2009; Zhang et al.,
2011). However, data emerging from clinical trials has revealed
substantial variability regarding CPAP treatment and its effects on
catecholamines levels,with some reporting a reduction in circulat-
ing catecholamines that extended into daytime and wakefulness,
while others did not ﬁnd any effect of CPAP treatment on cat-
echolamine concentrations (Ziegler et al., 2001; Bao et al., 2002;
Comondore et al., 2009). These discrepancies are probably and
partially explained by the fact that the therapeutic effect of CPAP
on blood pressure and sympathetic outﬂow is more prominent
in hypertensive patients when compared to normotensive OSA
patients (Heitmann et al., 2004). Mills et al. (2006) assessed the
effect of CPAP therapy on norepinephrine kinetics, and found
that CPAP treatment in OSA patients leads to a reduction in renal
sympathetic neural activity by enhancing the renal clearance of
norepinephrine rather than by attenuating norepinephrine syn-
thesis rates. Another important observation was recently reported
by Kohler and coworkers who studied the effect of CPAP with-
drawal in patients with OSA. These investigators showed that
CPAP withdrawal was not only accompanied by rapid recur-
rence of OSA symptoms, return of subjective sleepiness, impaired
endothelial function, and increases in blood pressure and heart
rate, but also by elevation in urinary catecholamines (Kohler et al.,
2011). Altogether, these studies seem to support the assumption
that OSA patients sustain elevations in catecholamine levels that
are attenuated by treatment, and are elevated again by treatment
withdrawal. These observations would make it plausible to con-
sider catecholamine levels in the blood or urine as a potentially
viable biomarker of OSA severity that can be used to monitor
patients responses to treatment (Comondore et al., 2009; Tasali
et al., 2011). However, the role of catecholamine levels as a valid
biomarker for diagnosis of OSA is not ﬁrmly established, most
likely because of the large amount of confounding factors and
associated morbidities that frequently accompany OSA and can
independently lead to changes in catecholamine levels. Indeed,
confounding factors such as age, hypertension, obesity, and the
use of anti-hypertensive medications are not easy to control for,
thereby increasing the difﬁculty to interpret at the individual
patient level the real impact of OSA on catecholamine levels.
In addition to clinical trials aiming to deﬁne the contribution
of each component of OSA to sympathetic activity, Foster et al.
(2009) conducted an experimental randomized controlled study
in humans in which they exposed 10 healthy men to 6 h/day of IH
or sham (2min cycles). After 4 days of IH, mean systemic blood
pressure increased by 4mmHg, and nitric oxide derivatives were
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reduced by 55%, the latter being associated with an increase in
the pressor response and in cerebral vascular resistance to hypoxia
(Foster et al., 2009). This study clearly supports previous ﬁnd-
ings demonstrating that hypoxemia elevates sympathetic nervous
system tone and exaggerates sympathetic basal activity in patients
withOSA (Leuenberger et al., 1995; Somers et al., 1995; Smith et al.,
1996; Imadojemu et al., 2007). Gilmartin et al. (2008) measured
changes in muscle sympathetic nerve activity (MSNA) in subjects
exposed to chronic sustainednocturnal hypoxia and found an aug-
mentedMSNA and a rise in blood pressure after 14 nights of expo-
sure. Recently, the same group (Gilmartin et al., 2010) conﬁrmed
these results in healthy subjects exposed to intermittent nocturnal
hypoxia (9 h/night) for 28 days. These investigators found aug-
mented MSNA with elevation of blood pressure after 2 weeks
of exposure, which further increase after 4 weeks of IH. Using
another aspect ofMSNAmeasurements combinedwith electrocar-
diogram recordings and consisting of assessments of sympathetic
burst latency in humans, several investigators (Morgan et al., 1996;
Xie et al., 1999) have shown that arousal from sleep, regardless
of whether it occurs spontaneously or is evoked by an apnea,
consistently elicits reductions in sympathetic burst latency. These
observations may reﬂect a temporary diminution of the barore-
ﬂex buffering of sympathetic outﬂow, and may play an important
role in the cardiovascularmorbidity induced by repetitive arousals
from sleep. Data from studies comparing OSA patients to controls
show a higher basal MSNA level in OSA patients, and also exag-
gerated MSNA responses to hypoxia, with treatment with CPAP
attenuating bothbasalMSNAandhypoxicMSNAresponses. Thus,
arterial chemoreﬂex sensitivity is increased in OSA and can be
reversed by treatment (Narkiewicz et al., 1999b; Usui et al., 2005;
Imadojemu et al., 2007).
As mentioned above, repetitive arousals are not only an impor-
tant component of OSA, but are also associated with state-related
increases in the sympathetic activity to peripheral arteries (Loredo
et al., 1999), which will usually lead to large repetitive blood
pressure rises as high as 60–80mmHg (Somers et al., 1989a).
In an experimental study of nine healthy humans, intra-thoracic
pressure changes induced by the Mueller maneuver were asso-
ciated with oscillations in blood pressure and increased SNA.
This is somewhat different from the time sequence of changes
in obstructive apnea, whereby SNA is initially increased, and the
bloodpressure elevationusually occurs later at the endof the apnea
(Somers et al., 1993b). Experimental paradigms of sleep disrup-
tion have demonstrated that sleep perturbations alone may play
an important role in the autonomic changes leading to the cardio-
vascularmorbidity observed inOSA. Leiter et al. (1985) studied 11
men and showed that a single night of sleep deprivation decreases
upper airway dilator muscle activity during hypercapnic rebreath-
ing, a response that may predispose to upper airway collapse. In
fact, loss of sleep is associated with reduced ventilatory responses
to hypercapnia and hypoxia, a response that potentially can deteri-
orate respiratory performance to airway obstruction (White et al.,
1983). It is possible that such changes in upper airway dynam-
ics may reﬂect altered ANS outputs to upper airway as discussed
above.
In summary, increases in sympathetic activity during sleepmay
be explained by the repetitive apneic events and their integral con-
stitutive elements. Remarkably, high sympathetic drive is present
even during daytime wakefulness, at a time that no respiratory
disturbances occur, and when both arterial oxygen saturation and
carbon dioxide levels are normal (Narkiewicz and Somers, 2003).
AUTONOMIC ALTERATIONS IN CHILDRENWITH OSA
For many years, the prevailing assumption was that children were
somewhat protected fromany cardiovascularmorbiditywith pedi-
atric OSA due to the redundancy of protective mechanisms, and
the increased vascular capacitance and reserve in children (see
Table 2 for summary). However, such assumptions have been dis-
proven in the last 15 years since the publication of initial papers by
Aljadeff et al. (1997) showing alteredANS function and byMarcus
et al. (1998) showing that elevations in blood pressure did occur
in children with relatively severe OSA.
Themechanismsunderlying cardiovascularmorbidities in chil-
dren most probably closely overlap the mechanisms leading to
suchmorbidity in adults. In a series of studies over the last decade,
our laboratory has shown that the combination of IH, sleep frag-
mentation, episodic hypercapnia, and increased intra-thoracic
pressure swings, can separately and in conjunction activate or
amplify the onset and propagation of endothelial dysfunction,
atherogenesis, increased systemic inﬂammation, oxidative stress,
and activation of adhesion molecules and coagulation (Parish and
Somers, 2004; Gozal et al., 2007; Gozal and Kheirandish-Gozal,
Table 2 | Summary of autonomic nervous system alterations in children with OSA.
Modality Reference Effect
Blood pressure
monitoring
Marcus et al. (1998), O’Driscoll et al. (2009a,b), Kohyama et al.
(2003), Leung et al. (2006), Bixler et al. (2008), Amin et al. (2004)
Arterial blood pressure was increased in OSA children
and more pronounced during NREM sleep and during
arousals
Urine and blood
catecholamines
Snow et al. (2010), Kaditis et al. (2009), Oliveira et al. (2010), Kelly
et al. (2010), O’Driscoll et al. (2011), Nakra et al. (2008)
OSA patients exhibit severity-dependent elevations in
catecholamine levels which respond to treatment
Heart rate variability
(HRV)
Aljadeff et al. (1997), Baharav et al. (1999), Constantin et al. (2008),
Muzumdar et al. (2011)
OSA alters cardiac beat-to-beat variation that is most
prominent during slow heart rates. Improvements in
HRV occur after treatment
Peripheral arterial
tonometry (PAT), pulse
transit time (PTT)
O’Brien and Gozal (2005, 2007), Tauman et al. (2004), Katz et al.
(2003), Pillar et al. (2002), Brietzke et al. (2007), Foo et al. (2006),
Pepin et al. (2005), Paruthi and Chervin (2010)
Exaggerated sympathetic responses following vital
capacity sighs and ice-cold hand pressor tests. Unique
PTT signatures appear to be present in pediatric OSA
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2008; Kim et al., 2011) in parallel with the important process of
sustained activation of the sympathetic nervous system (Somers
et al., 1995). Furthermore, we have provided initial evidence that
the alterations in ANS function may be reﬂected by the presence
of either increased sympathetic nervous system tone, increased
responsiveness,or the emergence of sympathetic–parasympathetic
imbalance (Bhattacharjee et al., 2009).
Studies exploring alterations in autonomic function in children
with sleep disordered breathing are relatively sparse, particularly
because of the difﬁculties associated with invasive assessments
such as nerve recordings (Narkiewicz and Somers, 2003). There-
fore, all studies have resorted to non-invasive probing of the ANS.
Aljadeff et al. (1997) used HRV analyses including both linear
and non-linear dynamic analyses and Poincare scatter plots, and
showed the presence of substantial alterations in sympathetic
tone in children with OSAS. Similar ﬁndings were subsequently
reported using power spectral analysis of heart rate (Baharav et al.,
1999), whereby a sympathetic predominance during REM sleep
emerged in pediatric OSA patients. O’Brien and Gozal (2005)
measured sympathetic responses during wakefulness in 28 chil-
dren with sleep disordered breathing and in 29 healthy controls
using PAT, and demonstrated exaggerated sympathetic responses
following vital capacity sighs and ice-cold hand pressor tests in
the OSA group, thereby providing compelling evidence on the
presence of increased sympathetic reactivity during wakefulness
in children with OSA. Other studies using heart rate dynam-
ics have also suggested that sleep state and OSA are important
determinants of cardiac autonomic outﬂow that can be readily
assessed with these methods and potentially provide a diagnostic
algorithm (Shouldice et al., 2004; Deng et al., 2006). A reduc-
tion of the increased HR variability during sleep after treatment
was initially reported with adenotonsillectomy in OSA children
(Constantin et al., 2008), and subsequently conﬁrmed (Muzum-
dar et al., 2011).In another study that included 25 children (mean
age 10.2± 2.3 years) undergoing a diagnostic assessment for OSA,
and 25 age-matched healthy control subjects, all participants
underwent an overnight polysomnography and were subjected to
autonomic cardiovascular tests for the assessment of autonomic
function (head-up tilt test, Valsalva maneuver, and deep breath-
ing test). Increased basal sympathetic activity during wakefulness
and also impaired severity-dependent responses to the autonomic
challenges emerged (Montesano et al., 2010). Of note, periodic
arousals even when induced by non-respiratory events can also
trigger alterations in autonomic function in children (Walter et al.,
2009).
Another frequently used non-invasive tool for assessment of
changes in ANS tone is the measurement of pulse transit time
(PTT). Indeed, PTT may serve as yet another indicator of sym-
pathetic burst activity by measuring the delay from the initial LV
electrical depolarization in the electrocardiogram to the appear-
ance of the corresponding plethysmographic signal of the oxime-
try waveform at the wrist (Foo and Lim, 2006). In studies con-
ducted in healthy children in whom recordings of PAT and PTT
were simultaneously performed, it became apparent that arousals
were associated with predictable changes in both PAT and PTT,
thereby linking sympathetic discharges to non-invasive measures
in children (Pillar et al., 2002; Katz et al., 2003; Tauman et al.,
2004; O’Brien and Gozal, 2007). These ﬁndings further suggested
PTT as a potentially valuable diagnostic screening tool for OSA
and as a probe of sympathetic activity changes (Pepin et al.,
2005; Foo et al., 2006; Brietzke et al., 2007; Paruthi and Chervin,
2010).
In an effort to obtain more accurate correlates of sympathetic
activation in children,measurements of the concentrations of cat-
echolamines in plasma or urine specimens have also been explored
in pediatric OSA patients. Kaditis et al. (2009) measured uri-
nary catecholamines in 44 OSA children with different levels of
nocturnal hypoxemia,and also included10 control children.Nora-
drenaline and adrenaline urine levels correlated signiﬁcantly with
the obstructive apnea–hypopnea index. Since concentrations of
catecholamines were measured in morning urine specimens col-
lected after arousal from sleep, the signiﬁcant associations between
urinary catecholamines and polysomnographic indicesmost likely
reﬂect increased nocturnal activity of sympathetic neurons and
possibly of the adrenal medulla (Kaditis et al., 2009). In a larger
cohort, Snow et al. (2010) assessed 159 habitually snoring chil-
dren who underwent overnight polysomnography and collection
of theﬁrstmorning voidedurine sample tomeasure the concentra-
tions of norepinephrine, epinephrine, and dopamine. In a subset
of children, blood samples were also drawn for gene expression
of catecholamine-relevant genes. Children with OSA had sig-
niﬁcantly higher urinary norepinephrine and epinephrine levels,
but not dopamine, compared to habitual snorers (norepineph-
rine: 40.1± 24.7 ng/mg creatinine vs. 31.6± 16.2 ng/mg creati-
nine, P < 0.01; epinephrine: 6.4± 10.5 ng/mg vs. 4.5± 0.5 ng/mg,
P < 0.01). As previously shown by Kaditis et al. (2009), norepi-
nephrine and epinephrine levels were signiﬁcantly correlated with
polysomnographic indices, but there was no evidence that body
mass index contributed to this association (Snow et al., 2010).
Thus,altered sympathetic activity inOSApatients appears to occur
independently of the presence of obesity. In addition, Snow et al.
(2010) also showed a higher gene expression among genes that are
involved in the synthesis and transport of catecholamines, as well
as in selected important receptors, with such ﬁndings suggest-
ing the presence of increased bioavailability of catecholamines.
More recently, several groups have conﬁrmed that AHI is a signiﬁ-
cant independent predictor of noradrenaline and adrenaline levels
(Kelly et al., 2010; Oliveira et al., 2010; O’Driscoll et al., 2011). In
a different study, Nakra et al. (2008) assessed a small group of
obese children and adolescents in whom norepinephrine levels
were assessed hourly throughout the night before and after treat-
ment with CPAP for 3months. Catecholamine levels were reduced
after treatment in this cohort, further conﬁrming the effect of OSA
on sympathetic outﬂow.
Alterations in blood pressure are one of the important mor-
bidities linked to modiﬁcations in autonomic and sympathetic
function in OSA. As mentioned above, Marcus et al. (1998) were
the ﬁrst to report alterations in systemic blood pressure in chil-
dren. The potential reduction in baroreﬂex function that have
been clearly identiﬁed in animal models have also been reported
in children with OSA (McConnell et al., 2009). Accordingly, it is
not surprising that a number of investigative groups have explored
and reported the presence of systemic blood pressure alterations
associated with OSA in pediatric population, with such changes
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being more pronounced during NREM sleep and also associated
with arousals (Kohyama et al., 2003; Amin et al., 2004; Leung et al.,
2006; Bixler et al., 2008; O’Driscoll et al., 2009a,b). Furthermore,
severity-dependent alterations in LV functionwith decreased dias-
tolic and systolic contractility have also been clearly identiﬁed in
pediatric OSA (Amin et al., 2008; Ugur et al., 2008; Kaditis et al.,
2010).
In the past decades, the prevalence of obesity and diabetes
has greatly increased in industrialized countries, and both sleep
curtailment and SDB are becoming recognized as contributing
factors, alongside increased caloric intake, and decreased physical
activity. The autonomic nerve system is an important regulator
of metabolic function in major organs including the liver, adipose
tissue, muscle, and pancreas, whereby alterations in autonomic
function contribute to metabolic dysfunction and obesity (Enri-
ori et al., 2011; Lambert et al., 2011; Straznicky et al., 2011).
Since as discussed earlier, sleep disorders are strongly connected
to autonomic dysfunction, the connection between sleep dis-
turbances, autonomic alterations, and metabolic morbidities is
becoming increasingly apparent (Spiegel et al., 2004; Trombetta
et al., 2010).
SUMMARY
Considering the close relationships between sleep regulatory
mechanisms and autonomic nerve system function described
heretofore, any sleep disturbance can theoretically lead to alter-
ations in sympathetic activity, and may thus elicit metabolic
and cardiovascular morbidities. Conclusive evidence has become
available to indicate that OSA components lead to pathological
activation of the sympathetic nervous system and contribute to
the pathophysiology of high bloodpressure, arrhythmias, and con-
gestive heart failure in adults. In children, there is increasing data
indicating that OSA can lead to changes in heart rate responses
and elevated blood pressure. Importantly, OSA treatment using
CPAP or upper airway surgical procedures will lead to attenua-
tion of the heightened sympathetic activity, which in turn will
lower blood pressure levels and reduce cardiovascular morbidities
in adults and children. Thus, the importance of autonomic per-
turbations in the context of sleep disorders becomes apparent and
can promote metabolic, cardiovascular, and psychological mor-
bidities throughout life. Data from rodent studies further show
that there are long-term implications to the autonomic nerve
system perturbations that occur during developmental windows
in infancy and childhood in response to OSA, particularly in
the context of underlying genetic predisposing factors that gov-
ern cardiovascular and metabolic disease susceptibility (Vallee
et al., 1996; Young, 2002; Van den Hove et al., 2006; Mastorci
et al., 2009). In the clinical context, utilization of catecholamine
levels as a potential biomarker for OSA in the context of diag-
nosis and adherence to therapy is intriguing and merits further
validation.
ACKNOWLEDGMENTS
Leila Kheirandish-Gozal is supported by NIH grant K12 HL-
090003; David Gozal is supported by National Institutes of Health
grants HL-065270 and HL-086662.
REFERENCES
Ai, J.,Wurster, R. D., Harden, S. W., and
Cheng, Z. J. (2009). Vagal afferent
innervation and remodeling in the
aortic arch of young-adult Fischer
344 rats following chronic inter-
mittent hypoxia. Neuroscience 164,
658–666.
Aljadeff, G., Gozal, D., Schechtman, V.
L., Burrell, B., Harper, R. M., and
Ward, S. L. (1997). Heart rate vari-
ability in children with obstructive
sleep apnea. Sleep 20, 151–157.
Amin, R., Somers, V. K., Mcconnell,
K., Willging, P., Myer, C., Sher-
man, M., Mcphail, G., Morgenthal,
A., Fenchel, M., Bean, J., Kimball,
T., and Daniels, S. (2008). Activity-
adjusted 24-hour ambulatory blood
pressure and cardiac remodel-
ing in children with sleep disor-
dered breathing. Hypertension 51,
84–91.
Amin, R. S., Carroll, J. L., Jeffries, J.
L., Grone, C., Bean, J. A., Chini,
B., Bokulic, R., and Daniels, S. R.
(2004). Twenty-four-hour ambula-
tory blood pressure in children with
sleep-disordered breathing. Am. J.
Respir. Crit. Care Med. 169, 950–956.
Andersen, M. L., Martins, P. J.,
D’Almeida, V., Bignotto, M., and
Tuﬁk, S. (2005). Endocrinological
and catecholaminergic alterations
during sleep deprivation and recov-
ery in male rats. J. Sleep Res. 14,
83–90.
Andersen, M. L., Martins, P. J.,
D’Almeida, V., Santos, R. F., Big-
notto, M., and Tuﬁk, S. (2004).
Effects of paradoxical sleep depriva-
tion on blood parameters associated
with cardiovascular risk in aged rats.
Exp. Gerontol. 39, 817–824.
Antic, V., Van Vliet, B. N., and Mon-
tani, J. P. (2001). Loss of noctur-
nal dipping of blood pressure and
heart rate in obesity-induced hyper-
tension in rabbits. Auton. Neurosci.
90, 152–157.
Aston-Jones, G., and Bloom, F. E.
(1981). Activity of norepinephrine-
containing locus coeruleus neurons
in behaving rats anticipates
ﬂuctuations in the sleep-
waking cycle. J. Neurosci. 1,
876–886.
Aydin, M., Altin, R., Ozeren, A., Kart,
L., Bilge, M., and Unalacak, M.
(2004). Cardiac autonomic activ-
ity in obstructive sleep apnea:
time-dependent and spectral analy-
sis of heart rate variability using
24-hour Holter electrocardiograms.
Tex. Heart Inst. J. 31, 132–136.
Baharav, A., Kotagal, S., Rubin, B. K.,
Pratt, J., and Akselrod, S. (1999).
Autonomic cardiovascular control
in children with obstructive sleep
apnea. Clin. Auton. Res. 9, 345–351.
Baker-Herman, T. L., and Strey, K.
A. (2011). Similarities and differ-
ences in mechanisms of phrenic
and hypoglossal motor facilita-
tion. Respir. Physiol. Neurobiol. 179,
48–56.
Balachandran, J. S., Bakker, J. P.,
Rahangdale, S., Yim-Yeh, S., Mietus,
J. E., Goldberger, A. L., and Malho-
tra,A. (2012). Effect of mild, asymp-
tomatic obstructive sleep apnea on
daytime heart rate variability and
impedance cardiography measure-
ments. Am. J. Cardiol. 109, 140–145.
Bao, G., Metreveli, N., and Fletcher,
E. C. (1999). Acute and chronic
blood pressure response to recur-
rent acoustic arousal in rats. Am. J.
Hypertens. 12, 504–510.
Bao, G., Metreveli, N., Li, R., Tay-
lor, A., and Fletcher, E. C. (1997).
Blood pressure response to chronic
episodic hypoxia: role of the sym-
pathetic nervous system. J. Appl.
Physiol. 83, 95–101.
Bao, X., Nelesen, R. A., Loredo, J. S.,
Dimsdale, J. E., and Ziegler, M. G.
(2002). Blood pressure variability in
obstructive sleep apnea: role of sym-
pathetic nervous activity and effect
of continuous positive airway pres-
sure. Blood Press. Monit. 7, 301–307.
Baruzzi, A., Riva, R., Cirignotta, F., Zuc-
coni, M., Cappelli, M., and Lugaresi,
E. (1991). Atrial natriuretic pep-
tide and catecholamines in obstruc-
tive sleep apnea syndrome. Sleep 14,
83–86.
Bhattacharjee, R., Kheirandish-Gozal,
L., Pillar, G., and Gozal, D. (2009).
Cardiovascular complications of
obstructive sleep apnea syndrome:
evidence from children. Prog. Car-
diovasc. Dis. 51, 416–433.
Bianchi, A. M., Mendez, M. O., Fer-
rario, M., Ferini-Strambi, L., and
Cerutti, S. (2010). Long-term cor-
relations and complexity analysis
of the heart rate variability sig-
nal during sleep. Comparing normal
andpathologic subjects.Methods Inf.
Med. 49, 479–483.
Bixler, E. O., Vgontzas, A. N., Lin,
H. M., Liao, D., Calhoun, S.,
Fedok, F., Vlasic, V., and Graff, G.
(2008). Blood pressure associated
with sleep-disordered breathing in
a population sample of children.
Hypertension 52, 841–846.
Bixler, E. O., Vgontzas, A. N., Lin,
H. M., Ten Have, T., Leiby, B.
E., Vela-Bueno, A., and Kales,
A. (2000). Association of hyper-
tension and sleep-disordered
breathing. Arch. Intern. Med. 160,
2289–2295.
Frontiers in Neurology | Sleep and Chronobiology January 2012 | Volume 3 | Article 7 | 8
Hakim et al. Sympathetic alterations in pediatric sleep apnea
Bonsignore, M. R., Parati, G., Insalaco,
G., Castiglioni, P., Marrone, O.,
Romano, S., Salvaggio, A., Mancia,
G., Bonsignore, G., and Di Rienzo,
M. (2006). Baroreﬂex control of
heart rate during sleep in severe
obstructive sleep apnoea: effects
of acute CPAP. Eur. Respir. J. 27,
128–135.
Borgel, J., Sanner, B. M., Keskin, F., Bit-
tlinsky, A., Bartels, N. K., Buchner,
N., Huesing, A., Rump, L. C., and
Mugge, A. (2004). Obstructive sleep
apnea and blood pressure. Interac-
tion between the blood pressure-
lowering effects of positive airway
pressure therapy and antihyperten-
sive drugs. Am. J. Hypertens. 17,
1081–1087.
Brietzke, S. E., Katz, E. S., and Roberson,
D. W. (2007). Pulse transit time as
a screening test for pediatric sleep-
related breathing disorders. Arch.
Otolaryngol. Head Neck Surg. 133,
980–984.
Brooks, D., Horner, R. L., Floras, J. S.,
Kozar, L. F., Render-Teixeira, C. L.,
and Phillipson, E. A. (1999). Barore-
ﬂex control of heart rate in a canine
model of obstructive sleep apnea.
Am. J. Respir. Crit. Care Med. 159,
1293–1297.
Cano-Pumarega, I., Duran-Cantolla, J.,
Aizpuru, F., Miranda-Serrano, E.,
Rubio, R., Martinez-Null, C., De
Miguel, J., and Barbe, F. (2011).
Obstructive sleep apnea and sys-
temic hypertension: longitudinal
study in the general population.Am.
J. Respir. Crit. Care Med. 184, 1299–
1304.
Carlson, J. T., Hedner, J., Elam, M.,
Ejnell, H., Sellgren, J., and Wallin, B.
G. (1993). Augmented resting sym-
pathetic activity in awake patients
with obstructive sleep apnea. Chest
103, 1763–1768.
Chan, E., Steenland, H. W., Liu, H., and
Horner, R. L. (2006). Endogenous
excitatory drive modulating respi-
ratory muscle activity across sleep-
wake states. Am. J. Respir. Crit. Care
Med. 174, 1264–1273.
Cheezum, M. K., and Lettieri, C. J.
(2010). Obstructive sleep apnea pre-
senting as pseudopheochromocy-
toma. J. Clin. Sleep. Med. 6, 190–191.
Cheng, J. H., Hua, C. C., Chen, N. H.,
Liu, Y. C., and Yu, C. C. (2011).
Autonomic activity difference dur-
ing continuous positive airway pres-
sure titration in patients with
obstructive sleep apnea/hypopnea
syndrome with or without hyper-
tension. Chang Gung Med. J. 34,
410–417.
Choi, J. H., Yi, J. S., Lee, S. H., Kim,
C. S., Kim, T. H., Lee, H. M.,
Lee, B. J., and Chung, Y. S. (2011).
Effect of upper airway surgery on
heart rate variability in patients with
obstructive sleep apnoea syndrome.
J. Sleep Res. doi: 10.1111/j.1365-
2869.2011.00978.x. [Epub ahead of
print].
Comondore, V. R., Cheema, R., Fox,
J., Butt, A., John Mancini, G. B.,
Fleetham, J. A., Ryan, C. F., Chan,
S., and Ayas, N. T. (2009). The
impact of CPAP on cardiovascu-
lar biomarkers in minimally symp-
tomatic patients with obstructive
sleep apnea: a pilot feasibility ran-
domized crossover trial. Lung 187,
17–22.
Constantin, E., Mcgregor, C. D., Cote,
V., and Brouillette, R. T. (2008).
Pulse rate and pulse rate variability
decrease after adenotonsillectomy
for obstructive sleep apnea. Pediatr.
Pulmonol. 43, 498–504.
Cooper, V. L., Elliott, M. W., Pearson,
S. B., Taylor, C. M., Mohammed,
M. M., and Hainsworth, R. (2007).
Daytime variability of baroreﬂex
function in patients with obstruc-
tive sleep apnoea: implications
for hypertension. Exp. Physiol. 92,
391–398.
Dematteis,M., Julien,C.,Guillermet,C.,
Sturm, N., Lantuejoul, S., Mallaret,
M., Levy, P., and Gozal, E. (2008).
Intermittent hypoxia induces early
functional cardiovascular remodel-
ing in mice. Am. J. Respir. Crit. Care
Med. 177, 227–235.
Deng, Z. D., Poon, C. S., Arzeno, N. M.,
and Katz, E. S. (2006). Heart rate
variability in pediatric obstructive
sleep apnea. Conf. Proc. IEEE Eng.
Med. Biol. Soc. 1, 3565–3568.
Dernaika, T. A., Kinasewitz, G. T., and
Tawk, M. M. (2009). Effects of noc-
turnal continuous positive airway
pressure therapy in patients with
resistant hypertension and obstruc-
tive sleep apnea. J. Clin. Sleep. Med.
5, 103–107.
Dhillon, S., Chung, S. A., Fargher, T.,
Huterer, N., and Shapiro, C. M.
(2005). Sleep apnea, hypertension,
and the effects of continuous posi-
tive airway pressure. Am. J. Hyper-
tens. 18, 594–600.
Dodig, I. P., Pecotic, R., Valic, M., and
Dogas, Z. (2011). Acute intermit-
tent hypoxia induces phrenic long-
term facilitation which is modu-
lated by 5-HT(1A) receptor in the
caudal raphe region of the rat.
J. Sleep Res. doi: 10.1111/j.1365-
2869.2011.00948.x. [Epub ahead of
print].
Drager, L. F., Bortolotto, L. A.,
Figueiredo, A. C., Krieger, E. M.,
and Lorenzi, G. F. (2007). Effects
of continuous positive airway pres-
sure on early signs of atheroscle-
rosis in obstructive sleep apnea.
Am. J. Respir. Crit. Care Med. 176,
706–712.
Duran-Cantolla, J., Aizpuru, F.,
Montserrat, J. M., Ballester, E.,
Teran-Santos, J., Aguirrego-
moscorta, J. I., Gonzalez, M.,
Lloberes, P., Masa, J. F., De La Pena,
M., Carrizo, S., Mayos, M., and
Barbe, F. (2010). Continuous pos-
itive airway pressure as treatment
for systemic hypertension in people
with obstructive sleep apnoea:
randomised controlled trial. BMJ
341, c5991.
Eckert, D. J., Malhotra, A., and Jordan,
A. S. (2009). Mechanisms of apnea.
Prog. Cardiovasc. Dis. 51, 313–323.
Elenkov, I. J.,Wilder, R. L., Chrousos, G.
P., andVizi, E. S. (2000). The sympa-
thetic nerve – an integrative interface
between two supersystems: the brain
and the immune system. Pharmacol.
Rev. 52, 595–638.
Elmasry, A., Lindberg, E., Hedner,
J., Janson, C., and Boman, G.
(2002). Obstructive sleep apnoea
and urine catecholamines in
hypertensive males: a population-
based study. Eur. Respir. J. 19,
511–517.
Enriori, P. J., Sinnayah, P., Simonds,
S. E., Garcia Rudaz, C., and Cow-
ley, M. A. (2011). Leptin action
in the dorsomedial hypothalamus
increases sympathetic tone to brown
adipose tissue in spite of systemic
leptin resistance. J. Neurosci. 31,
12189–12197.
Everson, C. A., and Crowley, W. R.
(2004). Reductions in circulating
anabolic hormones induced by sus-
tained sleep deprivation in rats. Am.
J. Physiol. Endocrinol. Metab. 286,
E1060–E1070.
Faccenda, J. F., Mackay, T. W., Boon, N.
A., and Douglas, N. J. (2001). Ran-
domized placebo-controlled trial of
continuous positive airway pres-
sure on blood pressure in the
sleep apnea-hypopnea syndrome.
Am. J. Respir. Crit. Care Med. 163,
344–348.
Fenik, V. B., Davies, R. O., and Kubin,
L. (2005). REM sleep-like atonia of
hypoglossal (XII) motoneurons is
caused by loss of noradrenergic and
serotonergic inputs. Am. J. Respir.
Crit. Care Med. 172, 1322–1330.
Fletcher, E. C., Lesske, J., Behm, R.,
Miller, C. C., Stauss, H., and Unger,
T. (1992). Carotid chemorecep-
tors, systemic blood pressure, and
chronic episodic hypoxia mimick-
ing sleep apnea. J. Appl. Physiol. 72,
1978–1984.
Fletcher, E. C., Miller, J., Schaaf, J. W.,
and Fletcher, J. G. (1987). Urinary
catecholamines before and after tra-
cheostomy in patients with obstruc-
tive sleep apnea and hypertension.
Sleep 10, 35–44.
Fletcher, E. C.,Orolinova,N., and Bader,
M. (2002). Blood pressure response
to chronic episodic hypoxia: the
renin-angiotensin system. J. Appl.
Physiol. 92, 627–633.
Flierl, M. A., Rittirsch, D., Huber-
Lang, M., Sarma, J. V., and Ward,
P. A. (2008). Catecholamines-crafty
weapons in the inﬂammatory arse-
nal of immune/inﬂammatory cells
or opening Pandora’s box?Mol.Med.
14, 195–204.
Foo, J. Y., Bradley, A. P., Wilson,
S. J., Williams, G. R., Dakin,
C., and Cooper, D. M. (2006).
Screening of obstructive and cen-
tral apnoea/hypopnoea in chil-
dren using variability: a prelim-
inary study. Acta Paediatr. 95,
561–564.
Foo, J. Y., and Lim, C. S. (2006). Pulse
transit time as an indirectmarker for
variations in cardiovascular related
reactivity. Technol. Health Care 14,
97–108.
Foster,G. E.,Brugniaux, J.V.,Pialoux,V.,
Duggan, C. T., Hanly, P. J., Ahmed,
S. B., and Poulin, M. J. (2009).
Cardiovascular and cerebrovascular
responses to acute hypoxia following
exposure to intermittent hypoxia in
healthy humans. J. Physiol. (Lond.)
587, 3287–3299.
Friedman, O., and Logan, A. G. (2009).
Sympathoadrenal mechanisms in
the pathogenesis of sleep apnea-
related hypertension. Curr. Hyper-
tens. Rep. 11, 212–216.
Gapelyuk, A., Riedl, M., Suhrbier, A.,
Kraemer, J. F., Bretthauer, G., Mal-
berg, H., Kurths, J., Penzel, T., and
Wessel, N. (2011). Cardiovascular
regulation in different sleep stages
in the obstructive sleep apnea syn-
drome. Biomed. Tech. (Berl.) 56,
207–213.
Gilmartin, G. S., Lynch, M., Tamisier,
R., and Weiss, J. W. (2010). Chronic
intermittent hypoxia in humans
during 28 nights results in blood
pressure elevation and increased
muscle sympathetic nerve activity.
Am. J. Physiol. Heart Circ. Physiol.
299, H925–H931.
Gilmartin,G. S.,Tamisier,R.,Curley,M.,
and Weiss, J. W. (2008). Ventilatory,
hemodynamic, sympathetic ner-
vous system, and vascular reactivity
changes after recurrent nocturnal
sustained hypoxia in humans. Am.
J. Physiol. Heart Circ. Physiol. 295,
H778–H785.
www.frontiersin.org January 2012 | Volume 3 | Article 7 | 9
Hakim et al. Sympathetic alterations in pediatric sleep apnea
Golbidi, S., Badran, M., Ayas, N., and
Laher, I. (2011). Cardiovascular con-
sequences of sleep apnea. Lung.
PMID: 22048845. [Epub ahead of
print].
Gonzalez-Martin, M. C., Vega-
Agapito, M. V., Conde, S. V.,
Castaneda, J., Bustamante, R.,
Olea, E., Perez-Vizcaino, F., Gon-
zalez, C., and Obeso, A. (2011).
Carotid body function and ven-
tilatory responses in intermittent
hypoxia. Evidence for anomalous
brainstem integration of arterial
chemoreceptor input. J. Cell. Physiol.
226, 1961–1969.
Gonzalez-Martin, M. C., Vega-Agapito,
V., Prieto-Lloret, J., Agapito, M.
T., Castaneda, J., and Gonzalez,
C. (2009). Effects of intermittent
hypoxia on blood gases plasma cate-
cholamine and blood pressure. Adv.
Exp. Med. Biol. 648, 319–328.
Gozal, D., and Kheirandish-Gozal, L.
(2008). Cardiovascular morbidity
in obstructive sleep apnea: oxida-
tive stress, inﬂammation, and much
more. Am. J. Respir. Crit. Care Med.
177, 369–375.
Gozal, D., Kheirandish-Gozal, L.,
Serpero, L. D., Sans Capdev-
ila, O., and Dayyat, E. (2007).
Obstructive sleep apnea and
endothelial function in school-aged
nonobese children: effect of ade-
notonsillectomy. Circulation 116,
2307–2314.
Greenberg, H. E., Sica, A., Batson, D.,
and Scharf, S. M. (1999). Chronic
intermittent hypoxia increases sym-
pathetic responsiveness to hypoxia
and hypercapnia. J. Appl. Physiol. 86,
298–305.
Gu, H., Lin, M., Liu, J., Gozal, D.,
Scrogin, K. E., Wurster, R., Chap-
leau, M. W., Ma, X., and Cheng,
Z. J. (2007). Selective impairment
of central mediation of barore-
ﬂex in anesthetized young adult
Fischer 344 rats after chronic
intermittent hypoxia. Am. J.
Physiol. Heart Circ. Physiol. 293,
H2809–H2818.
Guilleminault, C., Lee, J. H., and Chan,
A. (2005). Pediatric obstructive sleep
apnea syndrome. Arch. Pediatr. Ado-
lesc. Med. 159, 775–785.
Guyenet, P. G. (2006). The sympathetic
control of blood pressure. Nat. Rev.
Neurosci. 7, 335–346.
Heitmann, J., Ehlenz, K., Penzel, T.,
Becker, H. F., Grote, L., Voigt, K.
H., Peter, J. H., and Vogelmeier,
C. (2004). Sympathetic activity is
reduced by nCPAP in hypertensive
obstructive sleep apnoea patients.
Eur. Respir. J. 23, 255–262.
Horner, R. L., Brooks, D., Kozar, L.
F., Tse, S., and Phillipson, E. A.
(1995). Immediate effects of arousal
from sleep on cardiac autonomic
outﬂow in the absence of breath-
ing in dogs. J. Appl. Physiol. 79,
151–162.
Hornyak, M., Cejnar, M., Elam, M.,
Matousek, M., and Wallin, B. G.
(1991). Sympathetic muscle nerve
activity during sleep in man. Brain
114(Pt 3), 1281–1295.
Hui, A. S., Striet, J. B., Gudelsky, G.,
Soukhova, G. K., Gozal, E., Beitner-
Johnson, D., Guo, S. Z., Sachleben,
L. R. Jr., Haycock, J. W., Gozal, D.,
and Czyzyk-Krzeska, M. F. (2003).
Regulation of catecholamines by
sustained and intermittent hypoxia
in neuroendocrine cells and sym-
pathetic neurons. Hypertension 42,
1130–1136.
Hui, D. S., To, K. W., Ko, F. W., Fok, J.
P., Chan, M. C., Ngai, J. C., Tung,
A. H., Ho, C. W., Tong, M. W.,
Szeto, C. C., and Yu, C. M. (2006).
Nasal CPAP reduces systemic blood
pressure in patients with obstructive
sleep apnoea and mild sleepiness.
Thorax 61, 1083–1090.
Imadojemu, V. A., Mawji, Z., Kun-
selman, A., Gray, K. S., Hoge-
man, C. S., and Leuenberger, U.
A. (2007). Sympathetic chemoreﬂex
responses in obstructive sleep apnea
and effects of continuous positive
airway pressure therapy. Chest 131,
1406–1413.
Ip, M. S., Tse, H. F., Lam, B., Tsang, K.
W., and Lam,W.K. (2004). Endothe-
lial function in obstructive sleep
apnea and response to treatment.
Am. J. Respir. Crit. Care Med. 169,
348–353.
Iturriaga, R., Moya, E. A., and Del Rio,
R. (2009). Carotid bodypotentiation
induced by intermittent hypoxia:
implications for cardiorespiratory
changes induced by sleep apnoea.
Clin. Exp. Pharmacol. Physiol. 36,
1197–1204.
Kaditis, A. G., Alexopoulos, E. I.,
Dalapascha, M., Papageorgiou, K.,
Kostadima, E., Kaditis, D. G., Gour-
goulianis, K., and Zakynthinos, E.
(2010). Cardiac systolic function
in Greek children with obstructive
sleep-disordered breathing. Sleep
Med. 11, 406–412.
Kaditis, A. G., Alexopoulos, E. I.,
Damani, E., Hatzi, F., Chaidas, K.,
Kostopoulou, T., Tzigeroglou, A.,
and Gourgoulianis, K. (2009). Urine
levels of catecholamines in Greek
children with obstructive sleep-
disordered breathing. Pediatr. Pul-
monol. 44, 38–45.
Kara, T., Narkiewicz, K., and Somers,
V. K. (2003). Chemoreﬂexes –
physiology and clinical implica-
tions. Acta Physiol. Scand. 177,
377–384.
Kasai, T., and Bradley, T. D. (2011).
Obstructive sleep apnea and heart
failure: pathophysiologic and ther-
apeutic implications. J. Am. Coll.
Cardiol. 57, 119–127.
Katz, E. S., Lutz, J., Black, C., and
Marcus, C. L. (2003). Pulse
transit time as a measure of
arousal and respiratory effort in
children with sleep-disordered
breathing. Pediatr. Res. 53,
580–588.
Kelly, A., Dougherty, S., Cucchiara,
A., Marcus, C. L., and Brooks,
L. J. (2010). Catecholamines,
adiponectin, and insulin resistance
as measured by HOMA in children
with obstructive sleep apnea. Sleep
33, 1185–1191.
Kesek, M., Franklin, K. A., Sahlin, C.,
and Lindberg, E. (2009). Heart rate
variability during sleep and sleep
apnoea in a population based study
of 387 women. Clin. Physiol. Funct.
Imaging 29, 309–315.
Kim, J., Hakim, F., Kheirandish-
Gozal, L., and Gozal, D. (2011).
Inﬂammatory pathways in chil-
dren with insufﬁcient or disordered
sleep. Respir. Physiol. Neurobiol. 178,
465–474.
Kline, D. D. (2010). Chronic inter-
mittent hypoxia affects integration
of sensory input by neurons in
the nucleus tractus solitarii. Respir.
Physiol. Neurobiol. 174, 29–36.
Kohler, M., Pepperell, J. C., Casadei, B.,
Craig, S., Crosthwaite, N., Stradling,
J. R., and Davies, R. J. (2008). CPAP
and measures of cardiovascular risk
in males with OSAS. Eur. Respir. J.
32, 1488–1496.
Kohler, M., Stoewhas, A. C., Ayers, L.,
Senn, O., Bloch, K. E., Russi, E.
W., and Stradling, J. R. (2011). The
effects of CPAP therapy withdrawal
in patients with obstructive sleep
apnea: a randomised controlled trial.
Am. J. Respir. Crit. Care Med. 184,
1192–1199.
Kohler, M., and Stradling, J. R. (2010).
Mechanisms of vascular damage in
obstructive sleep apnea. Nat. Rev.
Cardiol. 7, 677–685.
Kohyama, J., Ohinata, J. S., and
Hasegawa, T. (2003). Blood pressure
in sleep disordered breathing. Arch.
Dis. Child. 88, 139–142.
Kubin, L., Davies, R. O., and Pack, A.
I. (1998). Control of upper airway
motoneurons during REM Sleep.
News Physiol. Sci. 13, 91–97.
La Rovere, M. T., Bigger, J. T. Jr.,
Marcus, F. I., Mortara, A., and
Schwartz, P. J. (1998). Baroreﬂex
sensitivity and heart-rate variabil-
ity in prediction of total cardiac
mortality after myocardial infarc-
tion. ATRAMI (autonomic tone
and reﬂexes after myocardial infarc-
tion) investigators. Lancet 351,
478–484.
Lai, C. J., Yang, C. C., Hsu, Y. Y., Lin, Y.
N., and Kuo, T. B. (2006). Enhanced
sympathetic outﬂow and decreased
baroreﬂex sensitivity are associated
with intermittent hypoxia-induced
systemic hypertension in conscious
rats. J. Appl. Physiol. 100, 1974–1982.
Lambert, E., Straznicky, N. E., Dawood,
T., Ika-Sari, C., Grima, M., Esler, M.
D., Schlaich, M. P., and Lambert,
G. W. (2011). Change in sympa-
thetic nerve ﬁring pattern associated
with dietary weight loss in the meta-
bolic syndrome. Front. Physiol. 2:52.
doi:10.3389/fphys.2011.00052
Leiter, J. C., Knuth, S. L., and Bartlett, D.
Jr. (1985). The effect of sleep depri-
vationon activity of the genioglossus
muscle. Am. Rev. Respir. Dis. 132,
1242–1245.
Lesske, J., Fletcher, E. C., Bao, G.,
and Unger, T. (1997). Hyperten-
sion caused by chronic intermittent
hypoxia – inﬂuence of chemorecep-
tors and sympathetic nervous sys-
tem. J. Hypertens. 15, 1593–1603.
Leuenberger, U., Jacob, E., Sweer, L.,
Waravdekar, N., Zwillich, C., and
Sinoway, L. (1995). Surges of mus-
cle sympathetic nerve activity dur-
ing obstructive apnea are linked
to hypoxemia. J. Appl. Physiol. 79,
581–588.
Leung, L. C., Ng, D. K., Lau, M. W.,
Chan, C. H., Kwok, K. L., Chow,
P. Y., and Cheung, J. M. (2006).
Twenty-four-hour ambulatory BP in
snoring children with obstructive
sleep apnea syndrome. Chest 130,
1009–1017.
Lin, M., Ai, J., Li, L., Huang, C., Chap-
leau,M.W., Liu, R., Gozal, D.,Wead,
W. B., Wurster, R. D., and Cheng,
Z. J. (2008). Structural remodeling
of nucleus ambiguous projections
to cardiac ganglia following chronic
intermittent hypoxia in C57BL/6J
mice. J. Comp. Neurol. 509, 103–117.
Lin, M., Liu, R., Gozal, D., Wead, W. B.,
Chapleau, M. W., Wurster, R., and
Cheng, Z. J. (2007). Chronic inter-
mittent hypoxia impairs baroreﬂex
control of heart rate but enhances
heart rate responses to vagal effer-
ent stimulation in anesthetizedmice.
Am. J. Physiol. Heart Circ. Physiol.
293, H997–H1006.
Frontiers in Neurology | Sleep and Chronobiology January 2012 | Volume 3 | Article 7 | 10
Hakim et al. Sympathetic alterations in pediatric sleep apnea
Loredo, J. S., Ziegler, M. G., Ancoli-
Israel, S., Clausen, J. L., and Dims-
dale, J. E. (1999). Relationship of
arousals from sleep to sympathetic
nervous system activity and BP in
obstructive sleep apnea. Chest 116,
655–659.
Lumeng, J. C., and Chervin, R. D.
(2008). Epidemiology of pediatric
obstructive sleep apnea. Proc. Am.
Thorac. Soc. 5, 242–252.
Mahamed,S., andMitchell,G. S. (2008).
Respiratory long-term facilitation:
too much or too little of a good
thing? Adv. Exp. Med. Biol. 605,
224–227.
Marcus, C. L., Greene, M. G., and Car-
roll, J. L. (1998). Blood pressure
in children with obstructive sleep
apnea. Am. J. Respir. Crit. Care Med.
157, 1098–1103.
Marrone, O., Salvaggio, A., Bue, A.
L., Bonanno, A., Riccobono, L.,
Insalaco, G., and Bonsignore, M.
R. (2011). Blood pressure changes
after automatic and ﬁxed CPAP in
obstructive sleep apnea: relationship
with nocturnal sympathetic activity.
Clin. Exp. Hypertens. 33, 373–380.
Mastorci, F., Vicentini, M., Viltart, O.,
Manghi, M., Graiani, G., Quaini, F.,
Meerlo, P., Nalivaiko, E., Maccari,
S., and Sgoifo, A. (2009). Long-term
effects of prenatal stress: changes
in adult cardiovascular regulation
and sensitivity to stress. Neurosci.
Biobehav. Rev. 33, 191–203.
McConnell, K., Somers, V. K., Kim-
ball, T., Daniels, S., Vandyke, R.,
Fenchel, M., Cohen, A., Willging, P.,
Shamsuzzaman, A., and Amin, R.
(2009). Baroreﬂex gain in children
with obstructive sleep apnea. Am. J.
Respir. Crit. Care Med. 180, 42–48.
Mills, P. J., Kennedy, B. P., Loredo, J.
S., Dimsdale, J. E., and Ziegler, M.
G. (2006). Effects of nasal contin-
uous positive airway pressure and
oxygen supplementation on norep-
inephrine kinetics and cardiovascu-
lar responses in obstructive sleep
apnea. J. Appl. Physiol. 100, 343–348.
Minemura,H.,Akashiba, T.,Yamamoto,
H., Akahoshi, T., Kosaka, N., and
Horie, T. (1998). Acute effects of
nasal continuous positive airway
pressure on 24-hour blood pressure
and catecholamines in patients with
obstructive sleep apnea. Intern. Med.
37, 1009–1013.
Molkov, Y. I., Zoccal, D. B., Moraes,
D. J., Paton, J. F., Machado, B.
H., and Rybak, I. A. (2011). Inter-
mittent hypoxia-induced sensitiza-
tion of central chemoreceptors con-
tributes to sympathetic nerve activ-
ity during late expiration in rats. J.
Neurophysiol. 105, 3080–3091.
Monahan,K.D., Leuenberger,U.A., and
Ray, C. A. (2006). Effect of repetitive
hypoxic apnoeas on baroreﬂex func-
tion in humans. J. Physiol. (Lond.)
574, 605–613.
Montesano, M., Miano, S., Paolino,
M. C., Massolo, A. C., Ianniello,
F., Forlani, M., and Villa, M. P.
(2010). Autonomic cardiovascular
tests in children with obstructive
sleep apnea syndrome. Sleep 33,
1349–1355.
Morgan, B. J., Crabtree, D. C., Puleo,
D. S., Badr, M. S., Toiber, F., and
Skatrud, J. B. (1996). Neurocircula-
tory consequences of abrupt change
in sleep state in humans. J. Appl.
Physiol. 80, 1627–1636.
Muzumdar, H. V., Sin, S., Nikova,
M., Gates, G., Kim, D., and
Arens, R. (2011). Changes in
heart rate variability after ade-
notonsillectomy in children with
obstructive sleep apnea. Chest 139,
1050–1059.
Nakra, N., Bhargava, S., Dzuira, J.,
Caprio, S., and Bazzy-Asaad, A.
(2008). Sleep-disordered breathing
in children with metabolic syn-
drome: the role of leptin and sym-
pathetic nervous system activity
and the effect of continuous posi-
tive airway pressure. Pediatrics 122,
e634–e42.
Narkiewicz, K., Kato, M., Phillips, B.
G., Pesek, C. A., Davison, D. E.,
and Somers, V. K. (1999a). Noctur-
nal continuous positive airway pres-
sure decreases daytime sympathetic
trafﬁc in obstructive sleep apnea.
Circulation 100, 2332–2335.
Narkiewicz, K., Van De Borne, P. J.,
Pesek, C. A., Dyken, M. E., Mon-
tano, N., and Somers, V. K. (1999b).
Selective potentiation of peripheral
chemoreﬂex sensitivity in obstruc-
tive sleep apnea. Circulation 99,
1183–1189.
Narkiewicz, K., and Somers, V. K.
(2003). Sympathetic nerve activity
in obstructive sleep apnoea. Acta
Physiol. Scand. 177, 385–390.
Newacheck, P. W., and Taylor, W. R.
(1992). Childhood chronic illness:
prevalence, severity, and impact.Am.
J. Public Health 82, 364–371.
Norman,D., Loredo, J. S.,Nelesen,R. A.,
Ancoli-Israel, S., Mills, P. J., Ziegler,
M. G., and Dimsdale, J. E. (2006).
Effects of continuous positive air-
way pressure versus supplemen-
tal oxygen on 24-hour ambulatory
blood pressure. Hypertension 47,
840–845.
O’Brien, L. M., and Gozal, D. (2005).
Autonomic dysfunction in chil-
dren with sleep-disordered breath-
ing. Sleep 28, 747–752.
O’Brien, L. M., and Gozal, D. (2007).
Potential usefulness of noninvasive
autonomic monitoring in recogni-
tion of arousals in normal healthy
children. J. Clin. Sleep. Med. 3,
41–47.
O’Driscoll, D. M., Foster, A. M., Ng,
M. L., Yang, J. S., Bashir, F.,
Nixon, G. M., Davey, M. J., Ander-
son, V., Walker, A. M., Trinder,
J., and Horne, R. S. (2009a).
Acute cardiovascular changes with
obstructive events in children with
sleep disordered breathing. Sleep 32,
1265–1271.
O’Driscoll, D. M., Foster, A. M., Ng,
M. L., Yang, J. S., Bashir, F.,
Wong, S., Nixon, G. M., Davey,
M. J., Anderson, V., Walker, A. M.,
Trinder, J., and Horne, R. S. (2009b).
Central apnoeas have signiﬁcant
effects on blood pressure and heart
rate in children. J. Sleep Res. 18,
415–421.
O’Driscoll, D. M., Horne, R. S., Davey,
M. J., Hope, S. A., Anderson, V.,
Trinder, J., Walker, A. M., and
Nixon,G.M. (2011). Increased sym-
pathetic activity in children with
obstructive sleep apnea: cardiovas-
cular implications. Sleep Med. 12,
483–488.
Oliveira, F. M., Tran, W. H., Lesser,
D., Bhatia, R., Ortega, R., Mittel-
man, S. D., Keens, T. G., David-
son Ward, S. L., and Khoo, M. C.
(2010). Autonomic and metabolic
effects of OSA in childhood obesity.
Conf. Proc. IEEE Eng. Med. Biol. Soc.
2010, 6134–6137.
Owens, R. L., Eckert, D. J., Yeh, S. Y.,
and Malhotra, A. (2008). Upper air-
way function in the pathogenesis of
obstructive sleep apnea: a review of
the current literature. Curr. Opin.
Pulm. Med. 14, 519–524.
Parish, J. M., and Somers, V. K. (2004).
Obstructive sleep apnea and cardio-
vascular disease.Mayo Clin. Proc. 79,
1036–1046.
Paruthi, S., and Chervin, R. D. (2010).
Approaches to the assessment of
arousals and sleep disturbance in
children. Sleep Med. 11, 622–627.
Patruno, V., Aiolﬁ, S., Costantino, G.,
Murgia, R., Selmi, C., Malliani, A.,
and Montano, N. (2007). Fixed
and autoadjusting continuous pos-
itive airway pressure treatments are
not similar in reducing cardiovas-
cular risk factors in patients with
obstructive sleep apnea. Chest 131,
1393–1399.
Pedrosa, R. P., Drager, L. F., Gon-
zaga, C. C., Sousa, M. G., De Paula,
L. K., Amaro, A. C., Amodeo, C.,
Bortolotto, L. A., Krieger, E. M.,
Bradley, T. D., and Lorenzi-Filho, G.
(2011). Obstructive sleep apnea: the
most common secondary cause of
hypertension associated with resis-
tant hypertension. Hypertension 58,
811–817.
Peng, Y. J., Nanduri, J., Zhang, X.,
Wang, N., Raghuraman, G., Seagard,
J. L., Kumar, G. K., and Prabhakar,
N. R. (2012). Endothelin-1 medi-
ates attenuated carotid baroreceptor
activity by intermittent hypoxia. J.
Appl. Physiol. 112, 187–196.
Peng, Y. J., Overholt, J. L., Kline,
D., Kumar, G. K., and Prab-
hakar, N. R. (2003). Induction of
sensory long-term facilitation in
the carotid body by intermittent
hypoxia: implications for recurrent
apneas. Proc. Natl. Acad. Sci. U.S.A.
100, 10073–10078.
Pepin, J. L., Delavie, N., Pin, I.,
Deschaux,C.,Argod, J.,Bost,M., and
Levy, P. (2005). Pulse transit time
improves detection of sleep respi-
ratory events and microarousals in
children. Chest 127, 722–730.
Pepperell, J. C., Ramdassingh-Dow, S.,
Crosthwaite, N., Mullins, R., Jenkin-
son, C., Stradling, J. R., and Davies,
R. J. (2002). Ambulatory blood
pressure after therapeutic and sub-
therapeutic nasal continuous posi-
tive airway pressure for obstructive
sleep apnoea: a randomised parallel
trial. Lancet 359, 204–210.
Perry, J. C., D’Almeida, V., Souza, F. G.,
Schoorlemmer,G.H.,Colombari,E.,
and Tuﬁk, S. (2007). Consequences
of subchronic and chronic expo-
sure to intermittent hypoxia and
sleep deprivation on cardiovascular
risk factors in rats. Respir. Physiol.
Neurobiol. 156, 250–258.
Pillar, G., Bar, A., Shlitner, A., Schnall,
R., Shefy, J., and Lavie, P. (2002).
Autonomic arousal index: an auto-
mated detection based on periph-
eral arterial tonometry. Sleep 25,
543–549.
Poupard, L., Court-Fortune, I., Pichot,
V., Chouchou, F., Barthelemy, J.
C., and Roche, F. (2011). Use
of high-frequency peak in spec-
tral analysis of heart rate increment
to improve screening of obstruc-
tive sleep apnoea. Sleep Breath 15,
837–843.
Prabha, K., Balan, K. V., Martin, R.
J., Lamanna, J. C., Haxhiu, M. A.,
and Dick, T. E. (2011). Chronic
intermittent hypoxia-induced aug-
mented cardiorespiratory outﬂow
mediated by vasopressin-VA recep-
tor signaling in the medulla. Adv.
Exp. Med. Biol. 701, 319–325.
Prabhakar, N. R., Fields, R. D., Baker, T.,
and Fletcher, E. C. (2001). Intermit-
tent hypoxia: cell to system. Am. J.
www.frontiersin.org January 2012 | Volume 3 | Article 7 | 11
Hakim et al. Sympathetic alterations in pediatric sleep apnea
Physiol. Lung Cell Mol. Physiol. 281,
L524–L528.
Prabhakar, N. R., and Kumar, G. K.
(2010). Mechanisms of sympathetic
activation and blood pressure
elevation by intermittent hypoxia.
Respir. Physiol. Neurobiol. 174,
156–161.
Prabhakar, N. R., Kumar, G. K., and
Nanduri, J. (2009). Intermittent
hypoxia-mediated plasticity of acute
O2 sensing requires altered red-ox
regulation byHIF-1 andHIF-2.Ann.
N. Y. Acad. Sci. 1177, 162–168.
Reeves, S. R., Guo, S. Z., Brittian, K. R.,
Row, B. W., and Gozal, D. (2006).
Anatomical changes in selected
cardio-respiratory brainstem nuclei
following early post-natal chronic
intermittent hypoxia. Neurosci. Lett.
402, 233–237.
Rey, S., Del Rio, R., Alcayaga, J.,
and Iturriaga, R. (2004). Chronic
intermittent hypoxia enhances
cat chemosensory and ventilatory
responses to hypoxia. J. Physiol.
(Lond.) 560, 577–586.
Robinson, G. V., Langford, B. A., Smith,
D. M., and Stradling, J. R. (2008).
Predictors of blood pressure fall with
continuous positive airway pressure
(CPAP) treatment of obstructive
sleep apnoea (OSA). Thorax 63,
855–859.
Rukhadze, I., and Kubin, L. (2007).
Differential pontomedullary cat-
echolaminergic projections to
hypoglossal motor nucleus and vis-
cerosensory nucleus of the solitary
tract. J. Chem. Neuroanat. 33, 23–33.
Schwimmer, H., Stauss, H. M., Abboud,
F., Nishino, S., Mignot, E., and
Zeitzer, J. M. (2010). Effects of
sleep on the cardiovascular and ther-
moregulatory systems: a possible
role for hypocretins. J. Appl. Physiol.
109, 1053–1063.
Shouldice, R. B., O’Brien, L. M.,
O’Brien, C., De Chazal, P., Gozal,
D., and Heneghan, C. (2004). Detec-
tion of obstructive sleep apnea in
pediatric subjects using surface lead
electrocardiogram features. Sleep 27,
784–792.
Smith,M. L.,Niedermaier,O. N.,Hardy,
S. M., Decker, M. J., and Strohl, K. P.
(1996). Role of hypoxemia in sleep
apnea-induced sympathoexcitation.
J. Auton. Nerv. Syst. 56, 184–190.
Smith, R. P., Veale, D., Pepin, J. L., and
Levy, P. A. (1998). Obstructive sleep
apnoea and the autonomic nervous
system. Sleep Med. Rev. 2, 69–92.
Snow, A., Gozal, D., Valdes, R. Jr., and
Jortani, S. A. (2010). Urinary pro-
teins for the diagnosis of obstructive
sleep apnea syndrome.Methods Mol.
Biol. 641, 223–241.
Somers, V. K., Dyken, M. E., Clary,
M. P., and Abboud, F. M. (1995).
Sympathetic neural mechanisms in
obstructive sleep apnea. J. Clin.
Invest. 96, 1897–1904.
Somers, V. K., Dyken, M. E., Mark,
A. L., and Abboud, F. M. (1993a).
Sympathetic-nerve activity during
sleep in normal subjects. N. Engl. J.
Med. 328, 303–307.
Somers, V. K., Dyken, M. E., and Skin-
ner, J. L. (1993b). Autonomic and
hemodynamic responses and inter-
actions during the Mueller maneu-
ver in humans. J. Auton. Nerv. Syst.
44, 253–259.
Somers, V. K., Mark, A. L., Zavala,
D. C., and Abboud, F. M. (1989a).
Contrasting effects of hypoxia and
hypercapnia on ventilation and sym-
pathetic activity in humans. J. Appl.
Physiol. 67, 2101–2106.
Somers,V. K.,Mark, A. L., Zavala, D. C.,
and Abboud, F. M. (1989b). Inﬂu-
ence of ventilation and hypocapnia
on sympathetic nerve responses to
hypoxia in normal humans. J. Appl.
Physiol. 67, 2095–2100.
Soukhova-O’Hare, G. K., Cheng, Z.
J., Roberts, A. M., and Gozal,
D. (2006a). Postnatal intermit-
tent hypoxia alters baroreﬂex
function in adult rats. Am. J.
Physiol. Heart Circ. Physiol. 290,
H1157–H1164.
Soukhova-O’Hare, G. K., Roberts, A.
M., and Gozal, D. (2006b). Impaired
control of renal sympathetic nerve
activity following neonatal intermit-
tent hypoxia in rats. Neurosci. Lett.
399, 181–185.
Soukhova-O’Hare, G. K., Ortines,
R. V., Gu, Y., Nozdrachev, A.
D., Prabhu, S. D., and Gozal,
D. (2008). Postnatal intermittent
hypoxia and developmental pro-
gramming of hypertension in spon-
taneously hypertensive rats: the role
of reactive oxygen species and L-
Ca2+ channels. Hypertension 52,
156–162.
Spaak, J., Egri, Z. J., Kubo, T., Yu,
E., Ando, S., Kaneko, Y., Usui, K.,
Bradley, T. D., and Floras, J. S.
(2005). Muscle sympathetic nerve
activity during wakefulness in heart
failure patients with and with-
out sleep apnea. Hypertension 46,
1327–1332.
Spiegel, K., Leproult, R., L’Hermite-
Baleriaux, M., Copinschi, G., Penev,
P. D., and Van Cauter, E. (2004).
Leptin levels are dependent on
sleep duration: relationships with
sympathovagal balance, carbohy-
drate regulation, cortisol, and thy-
rotropin. J. Clin. Endocrinol. Metab.
89, 5762–5771.
Stepanski, E. J. (2002). The effect
of sleep fragmentation on daytime
function. Sleep 25, 268–276.
Straznicky, N. E., Eikelis, N., Nestel, P. J.,
Dixon, J. B., Dawood, T., Grima, M.
T., Sari,C. I., Schlaich,M. P.,Esler,M.
D., Tilbrook, A. J., Lambert, G. W.,
and Lambert, E. A. (2011). Baseline
sympathetic nervous system activ-
ity predicts dietary weight loss in
obese metabolic syndrome subjects.
J. Clin. Endocrinol. Metab. PMID:
22090279. [Epub ahead of print].
Sukegawa, M., Noda, A., Sugiura, T.,
Nakata, S., Yoshizaki, S., Soga, T.,
Yasuda, Y., Iwayama, N., Nakai, S.,
and Koike, Y. (2005). Assessment
of continuous positive airway pres-
sure treatment in obstructive sleep
apnea syndrome using 24-hour uri-
nary catecholamines. Clin. Cardiol.
28, 519–522.
Suzuki, M., Guilleminault, C., Otsuka,
K., and Shiomi, T. (1996). Blood
pressure “dipping” and “non-
dipping” in obstructive sleep
apnea syndrome patients. Sleep 19,
382–387.
Suzuki, M., Otsuka, K., and Guillem-
inault, C. (1993). Long-term nasal
continuous positive airway pres-
sure administration can normal-
ize hypertension in obstructive
sleep apnea patients. Sleep 16,
545–549.
Tartar, J. L., Ward, C. P., Cordeira, J.
W., Legare, S. L., Blanchette, A. J.,
Mccarley, R. W., and Strecker, R.
E. (2009). Experimental sleep frag-
mentation and sleep deprivation in
rats increases exploration in an open
ﬁeld test of anxiety while increasing
plasma corticosterone levels. Behav.
Brain Res. 197, 450–453.
Tasali, E., Chapotot, F., Leproult, R.,
Whitmore, H., and Ehrmann, D.
A. (2011). Treatment of obstructive
sleep apnea improves cardiometa-
bolic function in young obese
women with polycystic ovary syn-
drome. J. Clin. Endocrinol. Metab.
96, 365–374.
Tauman, R., and Gozal, D. (2006). Obe-
sity and obstructive sleep apnea in
children. Paediatr. Respir. Rev. 7,
247–259.
Tauman, R., O’Brien, L. M., Mast, B.
T., Holbrook, C. R., and Gozal, D.
(2004). Peripheral arterial tonom-
etry events and electroencephalo-
graphic arousals in children. Sleep
27, 502–506.
Trombetta, I. C., Somers, V. K., Maki-
Nunes, C., Drager, L. F., Toschi-Dias,
E., Alves, M. J., Fraga, R. F., Rondon,
M.U.,Bechara,M.G.,Lorenzi-Filho,
G., and Negrao, C. E. (2010). Con-
sequences of comorbid sleep apnea
in the metabolic syndrome – impli-
cations for cardiovascular risk. Sleep
33, 1193–1199.
Ugur, M. B., Dogan, S. M., Sogut, A.,
Uzun, L., Cinar, F., Altin, R., and
Aydin, M. (2008). Effect of ade-
noidectomy and/or tonsillectomyon
cardiac functions in children with
obstructive sleep apnea. ORL J.
Otorhinolaryngol. Relat. Spec. 70,
202–208.
Usui, K., Bradley, T. D., Spaak, J.,
Ryan, C. M., Kubo, T., Kaneko, Y.,
and Floras, J. S. (2005). Inhibition
of awake sympathetic nerve activ-
ity of heart failure patients with
obstructive sleep apnea by noc-
turnal continuous positive airway
pressure. J. Am. Coll. Cardiol. 45,
2008–2011.
Vallee, M., Mayo, W., Maccari, S.,
Le Moal, M., and Simon, H.
(1996). Long-term effects of prena-
tal stress and handling on metabolic
parameters: relationship to corticos-
terone secretion response. Brain Res.
712, 287–292.
Van den Hove, D. L., Steinbusch, H.
W., Scheepens, A., Van De Berg,
W. D., Kooiman, L. A., Boosten, B.
J., Prickaerts, J., and Blanco, C. E.
(2006). Prenatal stress and neonatal
rat brain development. Neuroscience
137, 145–155.
Vargovic, P., Ukropec, J., Laukova, M.,
Cleary, S., Manz, B., Pacak, K., and
Kvetnansky, R. (2011). Adipocytes
as a new source of catecholamine
production. FEBS Lett. 585,
2279–2284.
Voogel, A. J., Van Steenwijk, R. P., Kare-
maker, J. M., and Van Montfrans,
G. A. (1999). Effects of treatment of
obstructive sleep apnea on circadian
hemodynamics. J. Auton. Nerv. Syst.
77, 177–183.
Walter, L.M., Foster,A.M., Patterson,R.
R.,Anderson,V.,Davey,M. J.,Nixon,
G. M., Trinder, J.,Walker, A. M., and
Horne, R. S. (2009). Cardiovascular
variability during periodic legmove-
ments in sleep in children. Sleep 32,
1093–1099.
Waters, K. A., and Gozal, D. (2003).
Responses to hypoxia during early
development. Respir. Physiol. Neuro-
biol. 136, 115–129.
Weiss, J. W., Liu, M. D., and Huang,
J. (2007). Physiological basis for a
causal relationship of obstructive
sleep apnoea to hypertension. Exp.
Physiol. 92, 21–26.
White, D. P., Douglas, N. J., Pick-
ett, C. K., Zwillich, C. W., and
Weil, J. V. (1983). Sleep depriva-
tion and the control of ventila-
tion. Am. Rev. Respir. Dis. 128,
984–986.
Frontiers in Neurology | Sleep and Chronobiology January 2012 | Volume 3 | Article 7 | 12
Hakim et al. Sympathetic alterations in pediatric sleep apnea
Wilcox, I., Grunstein, R. R., Hedner, J.
A., Doyle, J., Collins, F. L., Fletcher,
P. J., Kelly, D. T., and Sullivan, C.
E. (1993). Effect of nasal contin-
uous positive airway pressure dur-
ing sleep on 24-hour blood pressure
in obstructive sleep apnea. Sleep 16,
539–544.
Xie, A., Skatrud, J. B., Puleo, D. S., and
Morgan, B. J. (1999). Arousal from
sleep shortens sympathetic burst
latency in humans. J. Physiol. (Lond.)
515(Pt 2), 621–628.
Xing, T., and Pilowsky, P. M. (2010).
Acute intermittent hypoxia in rat
in vivo elicits a robust increase
in tonic sympathetic nerve activ-
ity that is independent of respira-
tory drive. J. Physiol. (Lond.) 588,
3075–3088.
Yan, B., Li, L., Harden, S. W., Gozal,
D., Lin, Y., Wead, W. B., Wurster, R.
D., and Cheng, Z. J. (2009). Chronic
intermittent hypoxia impairs heart
rate responses to AMPA and NMDA
and induces loss of glutamate recep-
tor neurons in nucleus ambiguous
of F344 rats. Am. J. Physiol. Regul.
Integr. Comp. Physiol. 296, R299–
R308.
Yan, B., Soukhova-O’Hare, G. K., Li,
L., Lin, Y., Gozal, D., Wead, W.
B., Wurster, R. D., and Cheng,
Z. J. (2008). Attenuation of heart
rate control and neural degenera-
tion in nucleus ambiguous follow-
ing chronic intermittent hypoxia in
young adult Fischer 344 rats. Neuro-
science 153, 709–720.
Young, J. B. (2002). Programming
of sympathoadrenal function.
Trends Endocrinol. Metab. 13,
381–385.
Young, T., Peppard, P. E., and Got-
tlieb, D. J. (2002). Epidemiol-
ogy of obstructive sleep apnea: a
population health perspective. Am.
J. Respir. Crit. Care Med. 165,
1217–1239.
Zhang, J.,Ma,R.C.,Kong,A. P.,So,W.Y.,
Li, A. M., Lam, S. P., Li, S. X., Yu, M.
W.,Ho,C. S.,Chan,M.H.,Zhang,B.,
andWing,Y. K. (2011). Relationship
of sleep quantity and quality with
24-hour urinary catecholamines
and salivary awakening cortisol in
healthymiddle-aged adults. Sleep 34,
225–233.
Ziegler, M. G. (2003). Sleep disorders
and the failure to lower nocturnal
blood pressure. Curr. Opin. Nephrol.
Hypertens. 12, 97–102.
Ziegler, M. G., Mills, P. J., Loredo,
J. S., Ancoli-Israel, S., and Dims-
dale, J. E. (2001). Effect of contin-
uous positive airway pressure and
placebo treatment on sympathetic
nervous activity in patients with
obstructive sleep apnea. Chest 120,
887–893.
Ziegler, M. G., Nelesen, R., Mills,
P., Ancoli-Israel, S., Kennedy, B.,
and Dimsdale, J. E. (1997). Sleep
apnea, norepinephrine-release rate,
and daytime hypertension. Sleep 20,
224–231.
Zoccal, D. B., Bonagamba, L. G.,
Paton, J. F., and Machado, B.
H. (2009). Sympathetic-mediated
hypertension of awake juvenile rats
submitted to chronic intermittent
hypoxia is not linked to barore-
ﬂex dysfunction. Exp. Physiol. 94,
972–983.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received: 07 December 2011; accepted:
10 January 2012; published online: 30
January 2012.
Citation: Hakim F, Gozal D and
Kheirandish-Gozal L (2012) Sympa-
thetic and catecholaminergic alterations
in sleep apnea with particular empha-
sis on children. Front. Neur. 3:7. doi:
10.3389/fneur.2012.00007
This article was submitted to Frontiers in
Sleep and Chronobiology, a specialty of
Frontiers in Neurology.
Copyright © 2012 Hakim, Gozal and
Kheirandish-Gozal. This is an open-
access article distributed under the terms
of the Creative Commons Attribution
Non Commercial License, which per-
mits non-commercial use, distribution,
and reproduction in other forums, pro-
vided the original authors and source are
credited.
www.frontiersin.org January 2012 | Volume 3 | Article 7 | 13
